10 results  1 of 1 

1 Analysis of risk factors associated with survival in human epidermal growth factor receptor 2-positive ductal carcinoma in situ using Korean Breast Cancer Society Database
Sol Ji Ahn, Chang Ik Yoon, Pill Sun Paik, Tae-Kyung Yoo, Namsun Park, Eun Sook Lee, Jung Eun Choi, Joon Jeong, Hyun Jo Youn, Woo-Chan Park
Ann Surg Treat Res.2021;101(6):315-321.   Published online 2021 December 1     DOI: http://dx.doi.org/10.4174/astr.2021.101.6.315
      
2 Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer
Ye Sul Jeong, Jun Kang, Jieun Lee, Tae-Kyung Yoo, Sung Hun Kim, Ahwon Lee
J Pathol Transl Med.2020;54(1):87-94.   Published online 2019 November 13     DOI: http://dx.doi.org/10.4132/jptm.2019.10.14
      
3 Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry
Kiho You, Sungmin Park, Jai Min Ryu, Isaac Kim, Se Kyung Lee, Jonghan Yu, Seok Won Kim, Seok Jin Nam, Jeong Eon Lee
J Breast Cancer.2017;20(3):297-303.   Published online 2017 September 22     DOI: http://dx.doi.org/10.4048/jbc.2017.20.3.297
      
4 Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
Katherine M. Krajewski, Marta Braschi-Amirfarzan, Pamela J. DiPiro, Jyothi P. Jagannathan, Atul B. Shinagare
Korean J Radiol.2017;18(1):28-41.   Published online 2017 January 5     DOI: http://dx.doi.org/10.3348/kjr.2017.18.1.28
      
5 Ductal Breast Carcinoma Metastatic to the Stomach Resembling Primary Linitis Plastica in a Male Patient
Biagio Ricciuti, Giulia Costanza Leonardi, Noemi Ravaioli, Andrea De Giglio, Marta Brambilla, Enrico Prosperi, Franca Ribacchi, Marialuisa Meacci, Lucio Crinò, Daniele Maiettini, Rita Chiari, Giulio Metro
J Breast Cancer.2016;19(3):324-329.   Published online 2016 September 23     DOI: http://dx.doi.org/10.4048/jbc.2016.19.3.324
      
6 Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study
Raffaella Marcheselli, Luigi Marcheselli, Laura Cortesi, Alessia Bari, Claudia Cirilli, Samantha Pozzi, Paola Ferri, Martina Napolitano, Massimo Federico, Stefano Sacchi
J Breast Cancer.2015;18(4):378-385.   Published online 2015 December 23     DOI: http://dx.doi.org/10.4048/jbc.2015.18.4.378
      
7 Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab Compared to Standard Trastuzumab-Based Chemotherapy Regimens for Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Potjana Jitawatanarat, Tracey L. O'Connor, Ellen B. Kossoff, Ellis G. Levine, Kaweesak Chittawatanarat, Nuttapong Ngamphaiboon
J Breast Cancer.2014;17(4):356-362.   Published online 2014 December 26     DOI: http://dx.doi.org/10.4048/jbc.2014.17.4.356
      
8 Correlation between HER2 Overexpression and Clinicopathological Characteristics in Gastric Cancer Patients Who Have Undergone Curative Resection
Ho Sung Son, Yeon Myung Shin, Kwang Kuk Park, Kyung Won Seo, Ki Young Yoon, Hee Kyung Jang, Sang-Ho Lee, Song I Yang, Jeong Hoon Kim
J Gastric Cancer.2014;14(3):180-186.   Published online 2014 September 30     DOI: http://dx.doi.org/10.5230/jgc.2014.14.3.180
      
9 Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients
June-Hyung Ha, Min-Ki Seong, Eun-Kyu Kim, Jin Kyung Lee, Hyesil Seol, Ju Young Lee, Jangmoo Byeon, Yeun-Ju Sohn, Jae Soo Koh, In-Chul Park, Woo Chul Noh, Hyun-Ah Kim
J Breast Cancer.2014;17(1):33-39.   Published online 2014 March 28     DOI: http://dx.doi.org/10.4048/jbc.2014.17.1.33
      
10 Association of Human Epidermal Growth Factor Receptor 2 with Radiotherapy Resistance in Patients with T1N0M0 Breast Cancer
Hyun-Ah Kim, Eun-Kyu Kim, Min-Soo Kim, Jong-Han Yu, Mi-Ri Lee, Hae Kyung Lee, Young-Jin Suh, Woo Chul Noh,
J Breast Cancer.2013;16(3):266-273.   Published online 2013 September 30     DOI: http://dx.doi.org/10.4048/jbc.2013.16.3.266
      

 1 of 1